ACADIA Pharmaceuticals Inc (ACAD)
15.09
+0.37
(+2.51%)
USD |
NASDAQ |
Oct 04, 16:00
15.09
0.00 (0.00%)
After-Hours: 20:00
ACADIA Pharmaceuticals Shareholders Equity (Annual): 431.76M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 431.76M |
| December 31, 2022 | 400.41M |
| December 31, 2021 | 540.89M |
| December 31, 2020 | 627.01M |
| December 31, 2019 | 699.14M |
| December 31, 2018 | 479.08M |
| December 31, 2017 | 335.28M |
| December 31, 2016 | 518.41M |
| December 31, 2015 | 199.76M |
| December 31, 2014 | 309.49M |
| December 31, 2013 | 182.13M |
| December 31, 2012 | 84.98M |
| Date | Value |
|---|---|
| December 31, 2011 | 23.36M |
| December 31, 2010 | 29.69M |
| December 31, 2009 | 12.11M |
| December 31, 2008 | 52.99M |
| December 31, 2007 | 113.93M |
| December 31, 2006 | 67.16M |
| December 31, 2005 | 39.37M |
| December 31, 2004 | 30.68M |
| December 31, 2003 | -52.67M |
| December 31, 2002 | -40.09M |
| December 31, 2001 | 17.86M |
| December 31, 2000 | -22.51M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
400.41M
Minimum
2022
699.14M
Maximum
2019
539.84M
Average
540.89M
Median
2021
Shareholders Equity (Annual) Benchmarks
| Biogen Inc | 14.80B |
| Madrigal Pharmaceuticals Inc | 405.33M |
| Supernus Pharmaceuticals Inc | 921.52M |
| Intra-Cellular Therapies Inc | 591.42M |
| Myomo Inc | 8.989M |